Journals / Kulak Burun Boğaz İhtisas Dergisi / 2002 / Cilt: 9 - Sayı: 3

Primary carcinoma of the subglottic larynx

Primer subglottik larenks kanseri

Pages
198–202
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The overall three-year survival rate was 73.4% (11/15).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Primary carcinoma of the subglottic larynx is very rare.
📊
Key Findings & Data:Patients and Methods: The study included 15 patients (14 men, 1 woman; mean age 62.8 years; range 45 to 95 years) with primary subglottic carcinoma.
💡
Conclusion & Impact:The overall three-year survival rate was 73.4% (11/15).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Larinjektomi · Karsinom · yassı hücreli

Abstract

Objectives: Primary carcinoma of the subglottic larynx is very rare. This study was designed to evaluate patients who were treated for primary carcinoma of the subglottic larynx. Patients and Methods: The study included 15 patients (14 men, 1 woman; mean age 62.8 years; range 45 to 95 years) with primary subglottic carcinoma. Correlations of different clinical parameters with three-year survival rate and Kaplan-Meier survival analysis were investigated. Results: On presentation, two patients (14%) had - T1, five patients (33%) had T2, three patients (20%) had T3, and five patients (33%) had T4 tumors. The overall three-year survival rate was 73.4% (11/15). The median survival calculated by the Kaplan-Meier method was 45 months. No significant differences were found between the survival rates of patients with and without extralaryngeal extension. Conclusion: Although primary subglottic cancer is locally aggressive with high tendency to extend to the extralaryngeal compartment at the time of diagnosis, high survival rates can be expected when appropriate treatment modalities are selected.

Özet

Amaç: Larenksin primer olarak subglottik bölgesinden kaynaklanan tümörler seyrek görülür. Bu çalışmada, primer subglottik kanserli hastalar ile ilgili gözlemlerimizi ve izlem sonuçlarımızı sunmayı amaçladık. Hastalar ve Yöntemler: Primer subglottik tümör nedeniyle tedavi edilen 15 hasta (14 erkek,1 kadın; ort. yaş 62.8; dağılım 45-95) incelendi. Hastaların, üç yıllık sağkalım oranları hesaplandı; Kaplan-Meier yaşam eğrileri çıkarıldı ve farklı klinik parametrelerin bu değerler üzerindeki olası etkileri araştırıldı. Bulgular: Tanı aşamasında tümör evreleri iki hastada (%14) T1, beş hastada (%33) T2, üç hastada (%20) T3, beş hastada (%33) T4 şeklindeydi. Üç yıl sonunda sağkalım oranı %73.4 (11/15) bulundu. Kaplan-Meier yöntemi ile hesaplanan medyan yaşam süresi 45 ay idi. Ekstralarenjeal uzanımı olan hastaların yaşam süreleri ile, larenkse sınırlı hastalık nedeniyle tedavi edilen olgular arasında anlamlı bir fark gözlenmedi. Sonuç: Primer subglottik larenks kanseri, lokal olarak agresif seyirli olmasına ve tanı anında larenks dışına yayılım olasılığı yüksek bulunmasına rağmen, uygun tedavi yönteminin seçimiyle yüksek sağkalım oranları elde edilebilir.

🔖

Cite This Article

ERDAMAR, B., SÜOĞLU, Y., EMİN, A. H. H., AKDAĞ, K., KIYAK, E., SUNAY, T., ÇÖLHAN, İ. (2002). Primary carcinoma of the subglottic larynx. Kulak Burun Boğaz İhtisas Dergisi, Cilt: 9 - Sayı: 3, 198–202. https://ajindex.com/articles/342973

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Dahm JD, Sessions DG, Paniello RC, Harvey J. Primary subglottic cancer. Laryngoscope 1998;108:741-6
  2. Sessions DG, Ogura JH, Fried MR Carcinoma of the subglottic area. Laryngoscope 1975;85:1417-23
  3. Ferlito A, Rinaldo A. The pathology and management of subglottic cancer. Eur Arch Otorhinolaryngol 2000;257:168-73
  4. Santoro R, Turelli M, Polli G. Primary carcinoma of the subglottic larynx. Eur Arch Otorhinolaryngol 2000; 257:548-51
  5. Vermund H. Role of radiotherapy in cancer of the larynx as related to the TNM system of staging. A review. Cancer 1970;25:485-504
  6. Lederman M. Radiotherapy of cancer of the larynx. J Laryngol Otol 1970;84:867-96
  7. McGavran M, Bauer W, Ogura J. The incidence of cervical lymphe node metastasis from epidermoid carcinoma of the larynx and their relationship to certain characteristics of the primary tumor. Cancer 1961;14:55-66
  8. Harrison DF. The pathology and management of subglottic cancer. Ann Otol Rhinol Laryngol 1971;80:6-12
  9. Beahrs OH. The larynx. In: Beahrs OH, editor. Manual for staging cancer of the American Joint Committee on Cancer. 4th ed. Philadelphia: J.B. Lippincott; 1992.p. 39-41
  10. Muntz H, Sessions D. Surgery of the laryngopharyn-geal and subglottic cancer. In: Bailey BJ, editor. Surgery of the larynx. 1st ed. Philadelphia: W.B. Saunders;1985. p. 311-4
  11. Lund WS. Classification of subglottic tumors and discussion of their growth and spread. Can J Otolaryngol 1974;3:469-72
  12. Kirchner JA. One hundred laryngeal cancers studied by serial section. Ann Otol Rhinol Laryngol 1969;78:689-709
  13. Hay lock BJ, Deutsch GP. Primary radiotherapy for subglottic carcinoma. Clin Oncol (R Coll Radiol) 1993;5:143-6
  14. Pietrantoni L, Agazzi C, Fior R. Indications for surgical treatment of cervical lymph nodes in cancer of the larynx and hypopharynx. Laryngoscope 1962;72:1511-27
  15. Thaler ER, Montone K, Tucker J, Weinstein GS.Delphian lymph node in laryngeal carcinoma: a whole organ study. Laryngoscope 1997;107:332-4
  16. Hosal IN, Onerci M, Turan E. Peristomal recurrence. Am J Otolaryngol 1993;14:206-8.